Advertisement

Topics

Capricor's DMD Cell Therapy Has HOPE, But Market Is Unsure

06:44 EST 16 Nov 2017 | SCRIP

Capricor will start a Phase II trial in the first quarter of 2018 for its regenerative cell therapy CAP-1002 in...

      

Related Stories

 

Original Article: Capricor's DMD Cell Therapy Has HOPE, But Market Is Unsure

NEXT ARTICLE

More From BioPortfolio on "Capricor's DMD Cell Therapy Has HOPE, But Market Is Unsure"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...